These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

80 related articles for article (PubMed ID: 3187199)

  • 1. Chronic primidone treatment in the rat: an animal model of primidone therapy.
    Carl GF; Smith ML
    Res Commun Chem Pathol Pharmacol; 1988 Sep; 61(3):365-76. PubMed ID: 3187199
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Treatment of canine epilepsy with primidone.
    Schwartz-Porsche D; Löscher W; Frey HH
    J Am Vet Med Assoc; 1982 Sep; 181(6):592-5. PubMed ID: 7141952
    [TBL] [Abstract][Full Text] [Related]  

  • 3. NTP technical report on the toxicity and metabolism studies of chloral hydrate (CAS No. 302-17-0). Administered by gavage to F344/N rats and B6C3F1 mice.
    Beland FA
    Toxic Rep Ser; 1999 Aug; (59):1-66, A1-E7. PubMed ID: 11803702
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Serum concentrations of primidone and its metabolites, phenylethylmalonamide and phenobarbital, in the dog.
    Yeary RA
    Am J Vet Res; 1980 Oct; 41(10):1643-5. PubMed ID: 7224290
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Serum concentrations and efficacy of phenytoin, phenobarbital, and primidone in canine epilepsy.
    Farnbach GC
    J Am Vet Med Assoc; 1984 May; 184(9):1117-20. PubMed ID: 6725128
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Physiologically based pharmacokinetics model of primidone and its metabolites phenobarbital and phenylethylmalonamide in humans, rats, and mice.
    El-Masri HA; Portier CJ
    Drug Metab Dispos; 1998 Jun; 26(6):585-94. PubMed ID: 9616196
    [TBL] [Abstract][Full Text] [Related]  

  • 7. On P-chlorphenylalanine interference with phenobarbital formation from primidone.
    Chodera A; Szafarek P; Nowakowska E; Szczawińska K; Godlewski J
    Acta Physiol Pol; 1981; 32(6):737-40. PubMed ID: 6216736
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Single-dose pharmacokinetics and anticonvulsant efficacy of primidone in mice.
    Leal KW; Rapport RL; Wilensky AJ; Friel PN
    Ann Neurol; 1979 May; 5(5):470-4. PubMed ID: 464548
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Efficacy of primidone in dogs with seizures unresponsive to phenobarbital.
    Farnbach GC
    J Am Vet Med Assoc; 1984 Oct; 185(8):867-8. PubMed ID: 6501043
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Chronic treatment of rats with primidone causes depletion of pteroylpentaglutamates in liver.
    Carl GF; Eto I; Krumdieck CL
    J Nutr; 1987 May; 117(5):970-5. PubMed ID: 3585552
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Anticonvulsant efficacy of the low-affinity partial benzodiazepine receptor agonist ELB 138 in a dog seizure model and in epileptic dogs with spontaneously recurrent seizures.
    Löscher W; Potschka H; Rieck S; Tipold A; Rundfeldt C
    Epilepsia; 2004 Oct; 45(10):1228-39. PubMed ID: 15461677
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Therapeutic serum concentrations of primidone and its metabolites, phenobarbital and phenylethylmalonamide in epileptic dogs.
    Cunningham JG; Haidukewych D; Jensen HA
    J Am Vet Med Assoc; 1983 May; 182(10):1091-4. PubMed ID: 6863121
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Anticonvulsant effect of primidone in the gerbil. Time course and significance of the active metabolites.
    Frey HH; Löscher W; Reiche R; Schultz D
    Pharmacology; 1984; 28(6):329-35. PubMed ID: 6728906
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Efficacy of primidone for seizure control in neonates and young infants.
    Sapin JI; Riviello JJ; Grover WD
    Pediatr Neurol; 1988; 4(5):292-5. PubMed ID: 3242532
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Primidone kinetics and analysis of its interactions with the major antiepileptic drugs].
    Ermani M; Giaretta D; Pellegrini A; Chemello R; Testa G
    Riv Neurol; 1983; 53(2):81-93. PubMed ID: 6879058
    [TBL] [Abstract][Full Text] [Related]  

  • 16. NTP Toxicology and Carcinogenesis Studies of Methyleugenol (CAS NO. 93-15-2) in F344/N Rats and B6C3F1 Mice (Gavage Studies).
    National Toxicology Program
    Natl Toxicol Program Tech Rep Ser; 2000 Jul; 491():1-412. PubMed ID: 12563349
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Blood and cerebrospinal fluid pharmacokinetics of primidone and its primary pharmacologically active metabolites, phenobarbital and phenylethylmalonamide in the rat.
    Nagaki S; Ratnaraj N; Patsalos PN
    Eur J Drug Metab Pharmacokinet; 1999; 24(3):255-64. PubMed ID: 10716065
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Bioavailability of primidone in epileptic patients.
    Bielmann P; Levac TH; Langlois Y; Tetreault L
    Int J Clin Pharmacol; 1974 Mar; 9(2):132-7. PubMed ID: 4208031
    [No Abstract]   [Full Text] [Related]  

  • 19. How worthwhile is plasma primidone level measurement?
    Eadie MJ; Heazlewood R; Tyrer JH
    Clin Exp Neurol; 1981; 18():123-31. PubMed ID: 6926381
    [TBL] [Abstract][Full Text] [Related]  

  • 20. NTP Toxicology and Carcinogenesis Studies of Primidone (CAS No. 125-33-7) in F344/N Rats and B6C3F1 Mice (Feed Studies).
    National Toxicology Program
    Natl Toxicol Program Tech Rep Ser; 2000 Sep; 476():1-290. PubMed ID: 12571687
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.